Stéphanie is involved in the field of innovation for over 20 years. She started her career at Genzyme a Sanofi company – the pioneering company in orphan drug development- where she has held various major positions. Among others she has led successfully the launch of two orphan drugs across Europe and has created and led Genzyme patient group relations team for Europe.
These last 10 years Stéphanie has played leading roles in biotech start-up companies being in charge of early and late stage orphan drug commercialisation planning for Europe, Middle-East and Africa region and responsible for the set-up of the European infrastructure/ organisation for North American companies.
She has recently started her own consultancy company providing services to pharmaceuticals companies developing orphan drugs. Stéphanie holds a degree in chemistry- specialisation in biochemistry (UCL- Belgium) and holds a 1-year MBA from Louvain School of Business (UCL).